Tang, W.; Zhou, J.; Zhao, W.; Lin, F.; Xue, L.; Guo, Y.
Molecular Subtype-Associated Response to Cyclophosphamide–Epirubicin–Cisplatin Regimen in Recurrent or Metastatic Adenoid Cystic Carcinoma: A Retrospective Single-Center Study. Cancers 2026, 18, 1847.
https://doi.org/10.3390/cancers18111847
AMA Style
Tang W, Zhou J, Zhao W, Lin F, Xue L, Guo Y.
Molecular Subtype-Associated Response to Cyclophosphamide–Epirubicin–Cisplatin Regimen in Recurrent or Metastatic Adenoid Cystic Carcinoma: A Retrospective Single-Center Study. Cancers. 2026; 18(11):1847.
https://doi.org/10.3390/cancers18111847
Chicago/Turabian Style
Tang, Wenbo, Jiuli Zhou, Wei Zhao, Fengjuan Lin, Liqiong Xue, and Ye Guo.
2026. "Molecular Subtype-Associated Response to Cyclophosphamide–Epirubicin–Cisplatin Regimen in Recurrent or Metastatic Adenoid Cystic Carcinoma: A Retrospective Single-Center Study" Cancers 18, no. 11: 1847.
https://doi.org/10.3390/cancers18111847
APA Style
Tang, W., Zhou, J., Zhao, W., Lin, F., Xue, L., & Guo, Y.
(2026). Molecular Subtype-Associated Response to Cyclophosphamide–Epirubicin–Cisplatin Regimen in Recurrent or Metastatic Adenoid Cystic Carcinoma: A Retrospective Single-Center Study. Cancers, 18(11), 1847.
https://doi.org/10.3390/cancers18111847
